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WSAS is a clinical epidemiological study, based on a
random population of 30000 individuals living in West
Sweden. After having answered a questionnaires, a ran-
dom population was invited to extensive clinical pheno-
typing. We here report lung function FENO data from 954
asthmatics and 1030 non-asthmatics. Asthma was defined
as “doctors diagnosis of asthma” and “ever asthma” +
“current asthma medication or symptoms common in
asthma”. According to GINA criteria, 57.6% of asthmatics
had controlled asthma, 29.3% partly controlled asthma
and, 13.1% uncontrolled asthma. Weekly night-time
asthma awakenings was reported by 12.6% of asthmatics.
The prevalence of emergency visits over the last year due
to asthma was 13.9% in non-smokers, 17.1% in ex-smo-
kers, and 31.6 in current smokers (p=0.006 for trend).
Mean %pred FEV1 was 105.3% in non-asthma and 96.9 in
asthma. In the non-asthma group, 29.4% of individuals
had FEV1 <100% predicted, whereas 52.6% of asthmatics
had <100% predicted FEV1. In the non-asthma group,
4.6% of individuals had FEV1 <80% predicted, whereas
14.8% of asthmatics had <80% predicted FEV1. Mean
FENO was 25.2 in asthma, and 19.9 in non-asthma
(P<0.001). Low FENO (<20ppb) was observed in 62.8% of
individuals in the non-asthma group, and 54% in the
asthma group. High FENO (>50 ppb) was observed in 3%
of the non-asthma group and 9.6% of the asthma group.
Asthma with significant severity, leading to emergency vis-
its, is common in the WSAS, and previous or current
smoking increase that risk. Furthermore, close to every
other individual with asthma report uncontrolled or partly
controlled disease. Despite significant disease severity in
this epidemiological setting, very few asthmatics express
low lung function or very high exhaled FENO. Neither
FEV1, nor FENO may be appropriate markers of disease
severity in an epidemiological setting. However, WSAS
may be utilized to further explore determinants of asthma
severity and their risk factors, which will be reported at
the meeting. This work was financed by the VBG Founda-
tion against asthma/allergy.
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